A Danish pharmaceutical group focused on treatments for brain diseases, including depression, schizophrenia, Parkinson’s disease, and Alzheimer’s-related conditions. The company develops and commercializes central nervous system therapies through a mix of proprietary drugs and partnerships, with key...
No congressional trades have been disclosed for H Lundbeck A/S Sponsored ADR (HLUY) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.